|
Video: What is a Stock Split?
|
|
PDL BioPharma is engaged in providing alternative sources of capital through royalty monetizations and debt facilities; acquiring commercial-stage products and launching companies for commercialization of these products; as well as transactions involving late clinical-stage or early commercial-stage therapeutics. Co.'s subsidiary, LENSAR, Inc., is a medical device company focused on delivering femtosecond cataract laser technology used in refractive cataract surgical procedures. Co. also has investment in Evofem Biosciences, Inc., a clinical-stage biopharmaceutical company engaged in developing and commercializing products to address unmet needs in women's sexual and reproductive health. According to our PDLI split history records, PDLI has had 2 splits. | |
|
PDLI (PDLI) has 2 splits in our PDLI split history database. The first split for PDLI took place on August 23, 2000. This was a 2 for 1 split, meaning for each share of PDLI owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. PDLI's second split took place on October 10, 2001. This was a 2 for 1 split, meaning for each share of PDLI owned pre-split, the shareholder now owned 2 shares. For example, a 2000 share position pre-split, became a 4000 share position following the split.
When a company such as PDLI splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the PDLI split history from start to finish, an original position size of 1000 shares would have turned into 4000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into PDLI shares, starting with a $10,000 purchase of PDLI, presented on a split-history-adjusted basis factoring in the complete PDLI split history.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
01/06/2021 |
|
Start price/share: |
$8.41 |
|
End price/share: |
$2.47 |
|
Starting shares: |
1,189.06 |
|
Ending shares: |
1,441.65 |
|
Dividends reinvested/share: |
$1.15 |
|
Total return: |
-64.39% |
|
Average Annual Total Return: |
-14.29% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$3,561.12 |
|
Years: |
6.70 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
01/06/2021 |
|
Start price/share: |
$8.41 |
|
End price/share: |
$2.47 |
|
Dividends collected/share: |
$1.15 |
|
Total return: |
-56.96% |
|
Average Annual Total Return: |
-11.83% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$4,304.02 |
|
Years: |
6.70 |
|
|
|
Date |
Ratio |
08/23/2000 | 2 for 1 | 10/10/2001 | 2 for 1 |
|
|